“The crises, while tragic, created an opportunity to rethink security of supply in terms of where things are manufactured, and DMC is positioned to lead the change. It has taken time to get to this point. Nobody really saw the benefit of shortening supply chains until we had these recent crises. And all of a sudden, everyone is talking about logistics.” Kelly Smith, VP R&D at DMC Biotech talks with Il Bioeconomista.
Interview by Mario Bonaccorso